You are about to leave DOPTELET.com/itp and go to an external page.
Please note that Sobi, Inc. is not responsible for the content of the website you are
about to visit.
Go back
You are about to leave DOPTELET.com/itp and go to an external page.
Please note that Sobi, Inc. is not responsible for the content of the website you are
about to visit.
Go back
Discover the Doptelet Copay
Assistance Program
Terms and Conditions
Let’s explore all of the Doptelet financial assistance options you can access to help manage the cost of chronic ITP treatment for low platelet counts, like the Doptelet copay card, free trial offer, and more.
You’re just 7 questions away from finding out! If you do qualify, you‘ll be able to pay as little as $0 for Doptelet.
Don’t want to financially commit to Doptelet before you know whether it’s a good fit for your ITP treatment or not? This free trial offer through Doptelet Connect will provide eligible new patients with a free 15-day supply of Doptelet. You can find the prescription and enrollment form (to be filled out by your doctor) for it below.
Doptelet Connect helps assist your doctor and their office to get patients their prescription of Doptelet
Doptelet Connect is one of several ways you can access treatment with Doptelet. Its Dedicated Care Coordinators will work with you and your doctor to find a pharmacy that can fill your prescription.
Here‘s how it works:
Your doctor‘s office can send your prescription to Doptelet Connect for review.
Dedicated Care Coordinators can help:
Dedicated Care Coordinators can help:
For more information, call 1-833-368-2663.
Care Coordinators are available Monday–Friday 8 AM–8 PM ET.
A pharmacy will contact you to confirm your delivery details before sending you Doptelet.
Find out what information you’ll need to get copay support through Doptelet Connect.
Eligible commercially insured patients may qualify for the Doptelet Connect program.
What’s the program?
Eligible patients must:
How to enroll:
Terms and Conditions
There are so many resources for you! Check out our helpful handouts and see which speak to you.
CHRONIC ITP RESOURCESINDICATION & IMPORTANT SAFETY INFORMATION
What is DOPTELET (avatrombopag)?
DOPTELET is a prescription medicine used to help treat low blood platelet counts in adults with chronic immune thrombocytopenia (ITP) when other treatments have not worked well enough. It is not known if DOPTELET is safe or works in children.
Who should not receive DOPTELET?
You should not receive DOPTELET if you have ever had a blood clot, are pregnant, plan to become pregnant or plan to breastfeed. It is not known if DOPTELET passes into breast milk or if DOPTELET may have unintended side effects for your unborn baby. Do not breastfeed during your treatment with DOPTELET and for at least 2 weeks after the last dose.
You should call your healthcare provider or get medical help right away if you have any of the signs or symptoms of a blood clot after getting DOPTELET. They can be life threatening or cause death.
Before taking DOPTELET, you should tell your healthcare provider about all your medical conditions and medicines including vitamins, supplements, and herbal remedies.
What are the possible side effects of DOPTELET?
For patients with chronic ITP, the most common side effects are headache, fatigue, bruising, nosebleeds, upper respiratory tract infection, joint pain, bleeding gums, purple or red spots on your skin (petechiae), and runny nose.
You Should Know: These are not all of the possible side effects for DOPTELET. For more information, ask your healthcare provider or review the Prescribing Information at https://www.doptelet.com/doptelet.pdf.
If you suspect that you have experienced a side effect, call your healthcare provider. You may also report them to the US Food and Drug Administration (FDA) at 1-800-FDA-1088.
For further information, please see full Prescribing Information, including the Patient Information Leaflet.
What is DOPTELET® (avatrombopag)?
DOPTELET is a prescription medicine used to help treat low blood platelet counts in adults with chronic immune thrombocytopenia (ITP) when other treatments have not worked well enough. It is not known if DOPTELET is safe or works in children.
Who should not receive DOPTELET?
You should not receive DOPTELET if you have ever had a blood clot, are pregnant, plan to become pregnant or plan to breastfeed. It is not known if DOPTELET
What is DOPTELET (avatrombopag)?
DOPTELET is a prescription medicine used to help treat low blood platelet counts in adults with chronic immune thrombocytopenia (ITP) when other treatments have not worked well enough. It is not known if DOPTELET is safe or works in children.
Who should not receive DOPTELET?
You should not receive DOPTELET if you have ever had a blood clot, are pregnant, plan to become pregnant or plan to breastfeed. It is not known if DOPTELET passes into breast milk or if DOPTELET may have unintended side effects for your unborn baby. Do not breastfeed during your treatment with DOPTELET and for at least 2 weeks after the last dose.
You should call your healthcare provider or get medical help right away if you have any of the signs or symptoms of a blood clot after getting DOPTELET. They can be life threatening or cause death.
Before taking DOPTELET, you should tell your healthcare provider about all your medical conditions and medicines including vitamins, supplements, and herbal remedies.
What are the possible side effects of DOPTELET?
For patients with chronic ITP, the most common side effects are headache, fatigue, bruising, nosebleeds, upper respiratory tract infection, joint pain, bleeding gums, purple or red spots on your skin (petechiae), and runny nose.
You Should Know: These are not all of the possible side effects for DOPTELET. For more information, ask your healthcare provider or review the Prescribing Information at https://www.doptelet.com/doptelet.pdf.
If you suspect that you have experienced a side effect, call your healthcare provider. You may also report them to the US Food and Drug Administration (FDA) at 1-800-FDA-1088.
For further information, please see full Prescribing Information, including the Patient Information Leaflet.
This website uses cookies. By continuing to
use this website, you consent to our use of these cookies. Read more about our use of cookies